LWMI
CTXR icon

Legacy Wealth Management (Idaho)’s Citius Pharmaceuticals CTXR Stock Holding History

Legacy Wealth Management (Idaho)’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-930
Closed -$1.15K – 937
2025
Q3 		$1.15K Buy
+930
New +$1.3K ﹤0.01% 606

Other funds holding CTXR

HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Legacy Wealth Management (Idaho)'s CTXR Position: Q4 2025 in Review

Legacy Wealth Management (Idaho) sold out of Citius Pharmaceuticals (CTXR) in Q4 2025, closing a stake of 930 shares — an estimated $1.15K sold.

Legacy Wealth Management (Idaho) first reported a position in CTXR in Q3 2025 and held it in 1 quarter. The position peaked at $1.15K in Q3 2025. 39 funds tracked by Wall St. Rank hold CTXR as of Q4 2025.

  • Legacy Wealth Management (Idaho) reported no remaining Citius Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 930 Citius Pharmaceuticals shares in Q4 2025, an estimated $1.15K.
  • Legacy Wealth Management (Idaho) first reported a position in Citius Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • Legacy Wealth Management (Idaho)'s Citius Pharmaceuticals position peaked at $1.15K in Q3 2025.
  • 39 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q4 2025.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q4 2025, filed 3 Feb 2026.